BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 1448646)

  • 21. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
    Paul J
    Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human growth hormone and Creutzfeldt-Jakob disease.
    Bol Asoc Med P R; 1988 Jul; 80(7):253-7. PubMed ID: 3048299
    [No Abstract]   [Full Text] [Related]  

  • 23. Transmission of Creutzfeldt-Jakob disease by investigative and therapeutic procedures.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(2):89-98. PubMed ID: 1932464
    [No Abstract]   [Full Text] [Related]  

  • 24. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
    Billette de Villemeur T
    Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
    [No Abstract]   [Full Text] [Related]  

  • 25. [Iatrogenic Creutzfeldt-Jakob disease. Lessons from cases secondary to extracted growth hormone in France].
    Billette de Villemeur T; Pradel A
    Transfus Clin Biol; 1994; 1(5):333-7. PubMed ID: 7812459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease, leukemia and growth hormone therapy.
    Can Dis Wkly Rep; 1989 Oct; 15(42):212. PubMed ID: 2691104
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.
    Fisman M
    N Engl J Med; 1986 Apr; 314(15):987-8. PubMed ID: 3515181
    [No Abstract]   [Full Text] [Related]  

  • 28. Creutzfeldt-Jakob disease after liver transplantation.
    Créange A; Gray F; Cesaro P; Adle-Biassette H; Duvoux C; Cherqui D; Bell J; Parchi P; Gambetti P; Degos JD
    Ann Neurol; 1995 Aug; 38(2):269-72. PubMed ID: 7654078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Creutzfeldt-Jakob disease secondary to treatment with growth hormone].
    Beauvais P; Billette de Villemeur T
    Presse Med; 1993 Jun; 22(23):1077-8. PubMed ID: 8415458
    [No Abstract]   [Full Text] [Related]  

  • 30. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.
    Mills JL; Schonberger LB; Wysowski DK; Brown P; Durako SJ; Cox C; Kong F; Fradkin JE
    J Pediatr; 2004 Apr; 144(4):430-6. PubMed ID: 15069388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten-year mortality from Creutzfeldt-Jakob disease in Cyprus.
    Papacostas S; Malikides A; Petsa M; Kyriakides T
    East Mediterr Health J; 2008; 14(3):715-9. PubMed ID: 18720636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creutzfeldt-Jakob disease.
    de Villemeur TB
    Handb Clin Neurol; 2013; 112():1191-3. PubMed ID: 23622328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.
    Brown P; Gibbs CJ; Rodgers-Johnson P; Asher DM; Sulima MP; Bacote A; Goldfarb LG; Gajdusek DC
    Ann Neurol; 1994 May; 35(5):513-29. PubMed ID: 8179297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prion diseases. Review of the literature on the light of two case reports of Creutzfeldt-Jakob disease].
    Skjaerpe KA; Tysnes OB; Mørk S
    Tidsskr Nor Laegeforen; 1996 Mar; 116(9):1081-5. PubMed ID: 8658476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Slow-virus encephalitis in subjects treated with growth hormone extract: unexpected risks of substitute therapy].
    Butturini L
    G Clin Med; 1986 Feb; 67(1):53. PubMed ID: 3539686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Creutzfeld-Jakob disease].
    Giraud P; Alpérovitch A; Chazot G
    Rev Prat; 1999 May; 49(9):948-53. PubMed ID: 11865459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion infections in Creutzfeldt-Jakob disease and its variants.
    Parker JC; Snyder JW
    Ann Clin Lab Sci; 1999; 29(2):112-7. PubMed ID: 10219698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.